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Abstract
Microvillus Inclusion Disease (MVID) is a congenital enteropathy characterized by accumulation 
of vesiculo-tubular endomembranes in the subapical cytoplasm of enterocytes, historically termed 
“secretory granules”. However, neither their identity nor pathophysiological significance is well 
defined. Using immunoelectron microscopy and tomography we studied biopsies from MVID 
patients (3x Myosin 5b mutations, 1x Syntaxin3 mutation) and compared them to controls and 
genome-edited CaCo2 cell models, harboring relevant mutations. Duodenal biopsies from two 
patients with novel Myosin 5b mutations and typical clinical symptoms showed unusual 
ultrastructural phenotypes: aberrant subapical vesicles and tubules were prominent in the 
enterocytes, though other histological hallmarks of MVID were almost absent (ectopic intra-/
intercellular microvilli, brush border atrophy). We identified these enigmatic vesiculo-tubular 
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organelles as Rab11-Rab8-positive recycling compartments of altered size, shape and location 
harboring the apical SNARE Syntaxin3, apical transporters Sodium-Hydrogen Exchanger 3 
(NHE3) and cystic fibrosis transmembrane conductance regulator (CFTR). Our data strongly 
indicate that in MVID disrupted trafficking between cargo vesicles and the apical plasma 
membrane is the primary cause of a defect of epithelial polarity and subsequent facultative loss of 
brush border integrity, leading to malabsorption. Furthermore, they support the notion that 
mislocalization of transporters, such as NHE3 substantially contributes to the reported sodium loss 
diarrhea.
Keywords
immunoelectron microscopy; electron tomography; Rab Small GTPases; Rab11a; Rab8a; Stx3; 
Myo5b; NHE3; hereditary enteropathy; congenital diarrheal disorder
1. INTRODUCTION
Microvillus inclusion disease (MVID; OMIM 251850) is a rare, usually fatal hereditary 
enteropathy characterized by quite remarkable, complex ultrastructural alterations (see (1, 
2), for the original descriptions and (3), for a review). Clinically, MVID presents with 
intractable watery diarrhea, partial sodium loss and nutrient malabsorption during the first 
days or months after birth (1, 4). Classical histological hallmarks are villus atrophy in the 
small intestine and partial absence of the epithelial brush border, together with aberrant 
intracellular accumulation of periodic acid-Schiff (PAS)-positive material (1, 2).
In the majority of genetically verified cases known so far (n=~70, our unpublished data) 
MVID results from mutations in the motor protein Myosin 5b (Myo5b; see (4), for a 
review), as first described by our group (5). Furthermore, we detected the mutated soluble 
N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein Syntaxin3 
(Stx3) to cause a less severe form of enteropathy, considered as a variant form of MVID (6). 
Mutations in both MYO5B and STX3 disrupt trafficking between apical cargo vesicles and 
the plasma membrane (7). However, neither MVID pathophysiology nor the subcellular 
phenotype of the affected absorptive cells (enterocytes) has been fully defined.
In particular, initial electron microscopy (EM) revealed several structural abnormalities 
specific for MVID (1). Firstly, the densely packed apical microvilli, normally forming the 
enterocytes’ brush border, are partially or totally disrupted. Secondly, microvilli of villus 
enterocytes do occur ectopically. They are either lining ~2 μm wide, spherical intracellular 
lumina (termed microvillus inclusions: (2)), or occur at the basolateral plasma membrane in 
brush-like assemblies. Thirdly, large number of spherical to elongated, ~200 nm-wide, 
vesicular compartments are observed in the subapical cytoplasm of both crypt and villus 
enterocytes. Because of their morphology they were tentatively interpreted as (aggregates of) 
“secretory granules” (1, 3) – bona fide exocytic compartments (8) that are normally confined 
to undifferentiated crypt cells (e.g., Ref. (9): Fig. 3, Ref. (10): Fig. 3, Ref. (11): Fig. 14), and 
differ from granules of Paneth cells, enteroendocrine cells or goblet cells. Cytochemical 
studies showed these conspicuous compartments in the enterocytes of MVID patients further 
as PAS-positive endomembrane networks (12), that were locally positive for brush border 
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constituents (13, 14). Nevertheless, the exact nature of these seemingly pleiomorphic 
organelles has not been defined, nor their possible relevance for the pathophysiology of 
MVID.
Here we thoroughly analyzed these compartments in tissue samples from patients, including 
two new cases with an unorthodox MVID phenotype, and in genome-edited human cell 
models by using complementary microscopy techniques. Our approach allowed us to 
identify these so far ill-defined structures as Rab11- and/or Rab8-positive recycling 
endomembrane compartments, enriched with relevant apical membrane proteins, such as 
Stx3 as well as sodium-hydrogen exchanger 3 (NHE3) and cystic fibrosis transmembrane 
conductance regulator (CFTR). The data strongly suggest disrupted trafficking between 
cargo vesicles and the apical plasma membrane as the primary defect in MVID. This 
presumably leads to loss of epithelial polarity and facultative brush border atrophy, 
accounting for the sodium loss diarrhea.
2. RESULTS
We studied duodenal, jejunal and colon biopsies from three patients with novel or with 
published MYO5B mutations and in one patient with a STX3 mutation, as well as genome 
edited CaCo2 cell models (6, 15), plus controls (i.e., patients with non-MVID related 
intestinal diseases; wildtype CaCo2 cells). Transmission electron microscopy (TEM) was 
combined with electron tomography, PAS-cytochemistry (16), immuno-EM, and –in case of 
limited material–immunofluorescence microscopy (IF). Furthermore, DNA sequence 
analysis was performed on blood samples from patient 1 and 2.
2.1. Clinical findings & Genetics
Patient 1 (male; MYO5B) had intermittent episodes of intractable diarrhea and poor growth 
from the first few months of life. MVID was diagnosed in his 5-year old sister during her 
first year of life, and the ultrastructural analyses of their diagnostic intestinal biopsies were 
suggestive of MVID. These affected siblings were born to consanguineous Asian parents. 
The affected sister could be weaned from total parenteral nutrition during her 4th year of life. 
Sanger sequencing of the complete coding region (40 exons) and all flanking exon-intron 
boundaries of the MYO5B gene encoding Myosin 5b was performed in the index patient, 
i.e., the older affected sibling of patient 1, revealing a homozygous MYO5B mutation c.
244G>A (p.Glu82Lys) in exon 3. Targeted sequencing of exon 3 in family members revealed 
the same mutation in homozygous state in patient 1 and in heterozygous state in both healthy 
parents. Results are based on NCBI mRNA reference sequence NM_001080467, in which 
the A of the ATG translation initiation codon was nucleotide 1. Primers are listed in 
Supplementary Table S1. The c.244G>A (p.Glu82Lys) mutation is very rare; it is not listed 
in public databases including the Exome aggregation consortium database, EXAC. The 
p.Glu82Lys mutation affects a highly conserved amino acid, and is a non-conservative 
amino acid substitution, which is likely to impact secondary protein structure, as these 
residues differ in polarity, charge, and size, all of which is supported by in-silico analyses 
(SIFT, PolyPhen2). The identified MYO5B missense mutation might still preserve residual 
Myo5b protein function.
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Patient 2 (male; MYO5B) is the second child of healthy Asian patients who were not aware 
of any consanguinity between them, and he has a healthy sister. He started to have an 
intractable secretory diarrhea from birth, requiring total parenteral nutrition. An analysis of 
the whole coding region and all splice-sites of MYO5B revealed homozygosity for a c.
414C>A (p.His138Gln) mutation in exon 4. The c.414C>A (p.His138Gln) mutation is very 
rare; it is not listed in public databases including the Exome aggregation consortium 
database, EXAC. The p.His138Gln mutation affects a highly conserved amino acid, and is a 
non-conservative amino acid substitution, which is likely to impact secondary protein 
structure, as these residues differ in polarity and size, all of which is supported by in silico 
analyses (SIFT, PolyPhen2).
Patient 3: MYO5B c.1323–2A>G was described previously (4, 17).
Patient 4: STX3 c.372_373dup (p.Arg125Leufs*7) was described previously (6).
2.2. TEM-morphology and PAS-cytochemistry
In the biopsies from all four MVID patients distinct accumulations of ~100 to 400nm-wide, 
pleomorphic endomembrane compartments occupied the subapical cytoplasm of a high 
percentage of enterocytes (Fig. 1A). Three-dimensional (3D) reconstruction using electron 
tomography confirmed mainly isolated vesicles, as well as partly branching, interconnected 
tubular compartments (Fig. 1B, C; Movie S1). These endomembrane aggregates reached 
frequently from the perinuclear area to the plasma membrane, or the terminal web, where 
still present. Neighboring, unaffected enterocytes and controls showed scattered vesicles and 
short tubules, likely early and recycling endosomes and/or exocytic vesicles. Similar patterns 
were seen in genome-edited and control CaCo2 cell models (see Fig. S1D in Ref. (15)).
In conventionally stained plastic- and cryo-sections the contents of the vesicles/tubules 
appeared homogeneously electron-dense or -lucent (Fig. 1A, B). Locally, dense 
compartments were continuous with lucent ones, including parts with mixed contents (Fig. 
1A). Dense vesicles/tubules were found preferentially, though not exclusively, in the crypts 
(Fig. 1B). Lucent ones occurred all along the villi, where they frequently surrounded also 
microvillus inclusions, but also sporadically in the crypts. The relative abundance of dense 
and lucent vesicles/tubules varied throughout the samples and between the patients. 
Genome-edited CaCo2 cell models showed predominantly lucent vesicles/tubules (see Fig. 
1G in Ref. (15)).
Consistent with previous studies (12), most of these vesicles/tubules proved PAS-positive 
(Fig. 1C, D, E); and so did late endosomes/multivesicular bodies, the huge, quite 
heterogeneous population of degradative compartments (lysosomes, autophagosomes; (Fig. 
1D, Figure S1D)), the glycocalyx and substances contained within the lumina of microvillus 
inclusions (Figure S1B). PAS-staining intensity of the vesicles/tubules was not uniform, but 
PAS-reactive material was also detectable within the lucent vesicles/tubules thanks to special 
preparation and incubation protocols (Fig. 1E, F; for further details see the Materials and 
methods paragraph). In control biopsies, we merely observed a few dense, ~200 nm wide, 
PAS-positive vesicles (and occasionally short tubules) in the apical cytoplasm of immature 
crypt enterocytes (Fig. 1G).
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Taken together, the vast majority of the subapically clustering vesicles and tubules in the 
here presented MVID patients and genome-edited human CaCo2 cell lines were identical to 
structures historically termed “secretory granules”, as originally described from enterocytes 
of MVID patients (1, 2).
The other ultrastructural hallmarks of MVID are shortened and/or lacking brush border 
microvilli, as well as microvillus inclusions and/or basolateral microvilli. Notably, these 
features were rare or possibly even absent in the newly described patients 1 and 2 with 
mutated MYO5B (based on data available so far; Figure S1A–C), but prominent in MYO5B 
patient 3 (see Fig. 4A in ref. (17)). Patient 4 with a STX3 mutation showed few microvillus 
inclusions, but consistently basolateral microvilli (see Fig. 1D in Ref. (6). Denuded 
enterocytes occurred regularly in this patient, not only along the villi, but prominently also 
in the crypts (Figure S1D); such features have so far not been reported in any case of MVID, 
but could be also observed in two other, yet undescribed cases with STX3 mutations (our 
unpublished observations). Table 1 summarizes the varying subcellular phenotypes in 
enterocytes from the MVID patients and in the cell models presented here. In addition, 
drawings (Figure 2) illustrate in a generalized manner the predominant ultrastructural 
features of MVID enterocytes as compared to healthy controls.
2.3. Immunolabeling
To characterize the enigmatic vesicles/tubules and attribute them to a well-defined class of 
organelles we performed immunogold labeling on thawed cryo-sections (complemented 
with IF and pre-embedding IEM for patient 2). Biopsies and CaCo2 lines were probed with 
antibodies against membrane proteins that control proper trafficking of apical cargo in 
polarized epithelia, but show unorthodox, subapical IF-signals in MVID tissues and models. 
Amongst them, the small GTPase Rab11 appeared as a highly promising candidate (17–19). 
Indeed, in MVID samples and all genome-edited cell models presented here Rab11 was 
consistently seen at the membranes of subapically accumulating vesicles/tubules (Fig. 3A–
C). To a minor extent Rab11 could also be detected in the cytoplasm, at the Trans Golgi 
network (TGN), brush border remnants and lateral plasma membrane domains (Tab. 2). 
Three different anti-Rab11/Rab11a antibodies gave almost identical results. Similarly, 
another key player in targeted transport of exocytic vesicles, Rab8a, also occurred regularly 
at the membranes of the subapical vesicles/tubules (Fig. 3D, E), in addition to its canonical 
distribution (Tab. 2). In the controls these markers were confined to their typical locations as 
reported from IEM (20–23) and IF-studies.
As a member of the Rab11-Rab8 cascade the t-SNARE Stx3 mediates fusion of exocytic 
vesicles with the apical plasma membrane (7, 24–26). In samples lacking functional Myo5b, 
Stx3 was consistently found associated with subapical vesicles/tubules (Fig. 4A, B) and 
throughout the subapical cytoplasm, together with only moderate labeling of the apical 
plasma membrane (Fig. 4B). In the controls, Stx3 was located predominantly at the brush 
border, whereas the STX3-mutant biopsy and the respective genome-edited CaCo2 cell 
models showed no labeling at all (Tab. 2).
Furthermore, of particular interest was the distribution of apical transporters, since 
mislocalization of NHE3 and CFTR had been reported from intestinal epithelia of MVID-
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patients (19, 27). In biopsies of duodenum from our MVID patients, anti-NHE3 strongly 
labeled lucent and dense vesicles/tubules (Fig. 4C, D), the endoplasmic reticulum, and to a 
minor extent, the brush border (Tab. 2). Similar results were obtained with HA StrepTactin II 
(HS) tagged NHE3 and CFTR expressed in the genome-edited CaCo2 models (e.g., Figure 
S3A, B). Controls showed normal distribution of NHE3 (and HS-CFTR). Double labeling 
experiments complemented these observations (Fig. 3E, Figure S2A, B), though the 
respective labeling densities were considerably lower than with one marker only. 
Occasionally, immunogold label of cargo (endogenous or tagged), Stx3 or Rab8a on the one 
hand, and Rab11a on the other hand, was apparently located at the very same, distinct 
structural entity (i.e., one and the same vesicle/tubule; e.g., Figure S2A).
Markers for late endosomes and (autophago)lysosomes specifically labeled their respective 
compartments (e.g., Lamp1 (Lysosomal acid membrane protein1): Fig. 4E; LBPA 
(Lysobisphosphatidic acid), or p62/SQSTM1 (sequestosome-1): data not shown). Subapical 
vesicles/tubules, however, remained generally unstained (Fig. 4E), except for very few cases 
where dense tubules were evidently connected with Lamp1-positive organelles.
In addition, we performed immunofluorescence microscopy for Rab11, Stx3 and NHE3 
(Figure 5) as well as pre-embedding IEM for Rab11 (not shown) with biopsies from patient 
2 because of limited material. The data generally supported our IEM findings and were 
consistent with the literature.
Finally, biopsy specimens from patient 4 with mutated STX3 provided the unique 
opportunity to document the IEM localization of endogenous Myo5b in the vicinity of 
vesicular compartments. Whereas control biopsies showed a rather inconspicuous 
distribution of Myo5b throughout the (sub)apical cytoplasm and at the apical plasma 
membrane, Myo5b was regularly found at membranes of the vesicles and tubules in 
enterocytes of patient 4 (Fig. 6A, B). Enterocytes from MVID patients with MYO5B 
mutations were devoid of label, except for some negligible background that could result 
from aberrant expression of Myo5b mutants (Figure 6C). Similar data were obtained from a 
Myo5b-rescue cell line (Myo5b KI HS-Myo5b: (15)). HS-Myo5b was found close to 
(Rab11-positive) vesicular/tubular compartments in the cell periphery (Figure S3C, D), at 
the apical plasma membrane in the vicinity of Stx3, and throughout the (sub)apical 
cytoplasm.
3. DISCUSSION
Ever since the original descriptions of MVID (1, 2) subapical aggregates of vesicles and 
tubules, tentatively interpreted as “secretory granules”, were consistently recognized as 
specific, pathological feature of crypt, but also villus enterocytes of most MVID patients 
investigated (28). EM-cytochemistry according to Thiéry (16) -the ultrastructural correlate to 
PAS-staining- showed these structures, as well as the abundant (autophago)lysosomes to 
account together for the broad band of intracellular PAS-staining seen with light microscopy 
((12) and the present study). However, further information on the identity and biochemical 
properties of these compartments has been scarce so far, except for two case reports, where 
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sporadically sucrase isomaltase (SI: (13)) or Lewis histo-blood group antigen Le-a (14) was 
detected by IEM.
In the present study we used complementary microscopy techniques for characterizing the 
MVID-specific vesicles/tubules in enterocytes from intestinal biopsies of patients and in the 
genome-edited CaCo2 cell models (altogether: x4 MYO5B, x2 STX3 mutations; see Tab. 1). 
Our comparative IEM analyses yielded highly congruent results (Tab. 2), irrespective of 
patient-specific variations of ultrastructural and clinical phenotypes and regardless of the 
MYO5B or STX3 mutations involved.
All members of the Rab11-Rab8 cascade, as well as the cargo molecules studied here were 
regularly located in association with the membranes of dense and lucent vesicles/tubules and 
throughout the subapical cytoplasm, in addition to their canonical distribution. These were 
Rab11/Rab11a, Rab8a and Stx3 or Myo5b, plus the transporters NHE3 and CFTR. Of them, 
Rab11a and Rab8a may serve as bona fide organelle markers for recycling system 
membranes (e.g., (20, 29–31)), though strict organelle classifications might fall short in the 
light of the highly disordered subcellular context of MVID. Most remarkable is the distinct, 
robust signal of Rab11/Rab11a (32–34) in the subapical cytoplasm of human and mouse 
tissues and cell models ((17–19, 35); and the present study). Given our previous observation 
(36) of ultrastructural similarities to branched recycling tubules (37), one could interpret this 
subapical vesiculo-tubular network as abnormally extended, aberrant apical recycling 
endosomes.
The data on NHE3 and CFTR distribution presented here in MVID biopsies and/or models 
support this explanation, since intracellular trafficking of these transporters involves 
recycling compartments (38–42). It would also be conceivable to emphasize the role of 
Rab11a in secretory trafficking (32, 43, 44). The expanded vesiculo-tubular Rab11a-
containing endomembrane system may reflect blockade of processing of constitutive and 
regulated secretory pathways through the apical recycling system. Both points of view are 
not mutually exclusive and furthermore compatible with the observed Rab8a distribution. As 
shown here by IEM, the partial mislocalization of Rab8a clearly included the subapical 
vesicles/tubules, though previously reported IF-patterns (18, 19, 35) appeared less defined as 
compared to Rab11a. Among others, Rab8a regulates biosynthetic traffic ((45–47), for 
review), and localizes, therefore, both to secretory vesicles and recycling compartments (20, 
48–54). In sum, we provided here a provisional diagnosis of MVID-specific sub-apical 
vesicules/tubules as abnormal Rab11-Rab8-positive endomembranes, harboring also 
mislocalized apical proteins, some of which are subject to recycling.
Our observation that proteins involved in apical vesicle traffic were differentially distributed 
throughout the endomembrane network in MVID enterocytes needs further detailed 
investigation. With the available antibodies it was possible to perform double labeling for 
Rab11a in comparison to Rab8a, Stx3 or NHE3 (but not for Rab8a together with Stx3 or 
NHE3). Unambiguous co-localization on the very same vesicle/tubule was rarely detectable, 
despite the robust labeling for these proteins across the entire subapical area. The failure to 
detect simultaneously Rab11a and Rab8a on one and the same vesicle/tubule is not 
surprising. The gross distribution of these Rab GTPases generally shows variable degrees of 
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overlap (55): from very low in many cell types (e.g. (56)), to quite high (e.g., (57, 58)). 
Moreover, according to current concepts of apical cargo exocytosis/recycling, Rab11a 
recruits Rab8a to the vesicles via guanine exchange factor interaction for proper transport to 
the apical domain (7, 59, 60). Thus, both Rab proteins are required for Myo5b to interact 
with the apical Stx3 (15). As Stx3 interacts with the GTPase activating factors for both 
Rab11a and Rab8a (15), the transient binding of the Rab proteins to the vesicles is soon 
terminated at the apical plasma membrane. The presumably narrow time-frame of co-
localization during the highly dynamic apical exocytosis/recycling (31, 61) likely reduces 
the probability of detecting such features by static IEM; not to forget also the limitations 
inherent to IEM-analyses of complex, extended 3D structures by using ultra-thin sections.
The seemingly not congruent distribution of Rab11a and apparently trapped cargo or Stx3 
points to the possible existence of sub-domains within the recycling system network, as, for 
example, defined previously by members of the family of Rab11-interacting proteins 
(Rab11-FIPs) (62, 63). Intriguingly, the sub-compartmentation of the MVID-specific 
subapical endomembranes postulated here does not seem to correlate directly with the 
allocation of the (still undefined) dense and +/− lucent matrix contents within these vesicles/
tubules. Thus, this hypothetical sub-compartmentation requires further analyses, as well as 
the previously reported phenomenon of cargo-selectivity in apical trafficking (15). In certain 
cases of mutated MYO5B, only selected apically destined cargoes apparently mislocalize 
subapically, while other cargoes do not (e.g. NHE3, CFTR, GLUT5 versus DPPIV, SI, APN: 
(15), and our unpublished results; see also (64) in this context). Conceivably, several apical 
trafficking routes, presumably diverging at the TGN or further upstream at the apical 
recycling endosomal compartment with its potential sub-compartmentation, should be taken 
into account.
Together, our major findings are as follows: Two MVID patients with novel MYO5B 
mutations presented with typical clinical symptoms and abundant subapical vesicles and 
tubules, but quite intact brush border and almost no ectopic microvilli. By using high-
resolution microscopy we identified the PAS-positive subapical compartments (historically: 
“secretory granules”) as Rab11a- and Rab8a-positive, vesiculo-tubular endomembranes of 
altered extension and position, possibly comprising different sub-compartments. Moreover, 
the vesiculo-tubular membranes regularly accommodated Stx3, a key element of vesicle 
exocytosis, as well as apical transporters (NHE3, CFTR). Loss of intestinal NHE3 function 
causes severe diarrhea in humans (65–67) and mice, suggesting again that NHE3 
mislocalization (15, 68) significantly contributes to the reported secretory diarrhea. Thus, we 
provide further substantial, IEM-based evidence for the concept of disrupted apical traffic (2, 
3, 15, 27) and mistargeting of pivotal apical transporters as the primary cause of diarrhea and 
malabsorption in MVID.
4. MATERIALS AND METHODS
4.1. Human biopsy samples and Genetics
Written informed consent from the patients’ parents was obtained and snap biopsies from 
duodenal, jejunal, and colonic sites were obtained. Written informed consent for testing of 
MVID genes or genome-wide testing was obtained from the patients’ parents following 
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genetic counseling. The study was approved by the Ethics committee of the Medical 
University of Innsbruck (study no. UN3987) according to the principles outlined by the 
Helsinki declaration.
Genomic DNA from leucocytes was extracted using the MagAttract DNA Mini M48 Kit 
(Qiagen, Hilden, Germany). PCR and sequencing was performed as reported (5).
4.2. Antibodies
The following primary antibodies were used: rabbit anti-Rab8a (56), rabbit anti-Rab11 
(71-5300, Zymed), rabbit anti-Rab11a (VU57: (69)), mouse anti-Rab11a (8H10: (70)), 
rabbit anti-Syntaxin3 (ab133750, Abcam), rabbit anti-NHE3/SLC9A3 (HPA036669, Sigma), 
mouse anti-LAMP1 (H4A3, Developmental Studies Hybridoma Bank), mouse anti-LBPA 
(courtesy by Jean Gruenberg), guinea pig anti-p62 (PROGEN), chicken anti-Myosin 5b (71), 
mouse anti-HA.11 (clone 16B12, Covance MMS-101R-500).
4.3. Immunofluorescence microscopy (IF)
Sample preparation of natively frozen tissue and microscopy have been described previously 
(15, 17).
4.4. Immunogold-EM of thawed cryo-sections (IEM)
We generally processed biopsy and CaCo2-cell culture samples as previously described (72), 
taking advantage of the improved ultrastructure preservation achieved with a slight 
modification of the method published by Pujol and colleagues (73). In particular, tissues/
cells were pre-fixed with 4% (w/v) formaldehyde dissolved in 0.1M phosphate buffer (pH 
7.2; 24 hrs up to several days (including sample shipment); RT), followed by post-fixation 
with 4% (w/v) formaldehyde in 0.1M sodium borate buffer (pH 11, 1hr; RT). Subsequent 
sample processing and indirect single and double labelling was performed according to 
standard protocols (74, 75). Bound primary antibodies were visualized by relevant secondary 
antibodies (IgG molecules) conjugated to colloidal gold (Fig. 6) and/or by secondary 
antibodies (Fab’ fragments) conjugated to Nanogold (Nanoprobes; Figs. 3, 4 S2, S3). For 
double labelling we applied primary antibodies simultaneously, followed by detection with 
Nanogold-conjugates and 10nm-colloidal gold conjugates (in that order; Figs. S2, S3D). 
Nanogold conjugates, and optionally colloidal gold conjugates were subjected to silver 
enhancement (HQ-Silver, Nanoprobes).
4.5. Pre-embedding IEM
Frozen tissue (patient #2) was freeze-substituted and rehydrated (76) followed by 
permeabilization with Triton X (0.05%, 30min at RT), indirect immunogold labelling (using 
Nanogold-conjugates), silver enhancement, en-bloc staining with OsO4 and UA and, finally, 
epoxy resin embedding (77).
4.6. PAS cytochemistry at EM-level
Standard incubations were performed according to Thiéry (16) as described (36). In case of 
weak staining (e.g., Fig. 1E) incubation with periodic acid (PA) and thiocarbohydrazide 
(TCH) was optionally extended up to 15hrs each (16), and/or silver proteinate treatment (SP) 
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was carried out at +50°C (78). Alternatively, formaldehyde-fixed biopsies were subjected to 
high-pressure freezing, freeze-substitution and resin embedding as described for native cell 
samples (15), followed by standard incubations (60 min PA, 120 min TCH, 30 min SP at RT: 
(16)) – an approach, that yielded considerably intensified PAS-reaction product (Fig. 1F).
4.7. Electron microscopy and electron tomography
EM and tomography were described previously (15, 72).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Ultrastructure, 3D-architecture and PAS-cytochemistry of subapical vesicles/tubules 
(representing the historically termed “secretory granules”) as seen in plastic sections from small 
intestinal biopsies of MVID and control patients (scale bars = 500nm)
A. Vesicular and tubular endomembrane compartments with electron-dense or -translucent 
contents below the brush border and terminal web (BB, TW) of villus enterocytes from a 
duodenum biopsy of MVID patient #1; transitions between dense and lucent compartments 
marked by arrows; standard uranyl acetate/lead section staining;
B. 2D slice from an electron tomographic reconstruction with contour lining (red) of dense 
compartments in a villus cell of patient #4 (taken from Movie S1); jejunum;
C. 3D model of the dense compartments outlined in Figure 1B; patient #4;
D. Cytochemical detection of darkly stained PAS-reactive material within tubular 
compartments and (autophago)lysosomes (L/A) in patient #2; duodenum, villus cell;
Vogel et al. Page 15
Traffic. Author manuscript; available in PMC 2018 July 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
E. Villus enterocyte from duodenum of patient #1 with only moderate PAS-reactivity of 
dense and lucent compartments after standard sample processing;
F. Same biopsy from patient #1 as in Figure 1E, but subjected to freeze-substitution instead 
of standard processing: distinct PAS-reactivity of subapical compartments is recognizable;
G. Control section from a patient with non-MVID related intestinal disease showing 
scattered PAS-positive, putative “secretory granules” in the periphery of a crypt enterocyte.
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Figure 2. Graphic representation (generalized) of ultrastructural features characterizing the 
enterocytes from MVID patients with mutated MYO5B or STX3
Villus enterocytes of MVID patients with MYO5B mutations are generally characterized by 
(i) subapical vesiculo-tubular endomembrane accumulations, historically termed “secretory 
granules” (shown in orange), (ii) brush-border microvilli (shown in green) that are locally 
greatly reduced in size and frequency, (iii) microvillus inclusions (and/or sporadic 
basolateral microvilli) and (iv) numerous, large (autophago)lysosomes (shown in brown). 
Villus enterocytes of patients with mutated STX3 show regularly (i) abundant subapical 
vesicles and tubules, (ii) facultative brush-border disintegration, (iii) ectopic microvilli, 
predominantly forming basolateral bundles (rather than lining cytoplasmic microvillus 
inclusions), (iv) (autophago)lysosomes. Undifferentiated crypt enterocytes of patients with 
mutated MYO5B or STX3 display (i) more or less prominent subapical clusters of vesicles 
and tubules, (ii) varying configurations of apical microvilli that appear either reduced in size 
and number (STX3 mutations) or normal (MYOB mutations). Healthy villus and crypt 
enterocytes are shown for comparison.
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Figure 3. Rab11 and Rab8 immunogold labelling of thawed ultra-thin cryo-sections from 
duodenum biopsies of MVID-patients (scale bars = 500nm)
A. Rab11 label of subapical vesicular and tubular endomembrane compartments with 
electron-lucent contents; villus cell of patient #3;
B. Rab11 label at dense compartments; crypt cell of patient #3;
C. Overview of Rab11 distribution in the (sub)apical region of villus enterocytes from 
patient #3;
D. Rab8a label at dense compartments in a crypt cell of patient #4;
E. Rab11a (arrow-heads) and Rab8a (arrows) label at membranes of subapical vesicles/
tubules in a villus cell of patient #3.
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Figure 4. Immunogold labelling of Stx3, NHE3 and Lamp1 in enterocytes of the small intestine 
from MVID-patients (cryo-sections; scale bars = 500nm)
A. Stx3 label throughout the subapical vesicle/tubule clusters in a villus cell of patient #3;
B. Stx3 label in the periphery of a villus cell from patient #1;
C. NHE3 label in a villus cell from patient #3;
D. NHE3 labelling of membranes, but locally also contents of the dense endomembrane 
compartments in a crypt cell from patient #4;
E. Lamp1 labelling of (autophago)lysosomes (L/A), but not subapical vesicles/tubules in a 
villus cell from patient #1.
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Figure 5. (Immuno-)fluorescence microscopy of duodenum biopsies from patient #2 and control 
(cryostat sections)
Rab11 (Figure 5A), Stx3 (Figure 5B) and NHE3 (Figure 5C) show diffuse staining 
throughout the subapical cytoplasm of the patient’s enterocytes, in addition to, or instead of 
their normal localization (Rab11, Stx3 or NHE3, respectively); scale bar = 10μm.
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Figure 6. Immunogold labelling of Myo5b in enterocytes from MVID- and control patients (cryo-
sections; scale bars = 500nm)
A. Diffuse Myo5b label throughout the apical cytoplasm in a villus cell of a control patient.
B. Myo5b label predominantly associated with vesicular endomembranes in the (sub)apical 
cytoplasm of a colon crypt cell from patient #4 with mutated STX3.
C. Virtual no Myo5b label in a villus cell from patient #3 with mutated MYO5B.
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